Two new Ebola vaccines to join DR Congo clinical trial
Editorial abstract
Two new Ebola vaccine candidates will be added to a clinical trial in the Democratic Republic of the Congo (DRC) as the country continues to battle a deadly outbreak caused by the Bundibugyo species of the virus.
This is not the publisher’s original article. Unreviewed abstracts are mechanically condensed from source-provided material; editor-reviewed abstracts have completed editorial review.Story classification
Topics
Public Health · High confidence · AutomaticStory-text match
Regions
Africa · High confidence · AutomaticStory-text location match